Biodesix Inc. (BDSX): Price and Financial Metrics

Biodesix Inc. (BDSX): $0.54

0.03 (-5.64%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add BDSX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#85 of 306

in industry

BDSX Price/Volume Stats

Current price $0.54 52-week high $2.04
Prev. close $0.57 52-week low $0.45
Day low $0.51 Volume 842,600
Day high $0.60 Avg. volume 443,451
50-day MA $0.72 Dividend yield N/A
200-day MA $1.31 Market Cap 78.93M

BDSX Stock Price Chart Interactive Chart >


Biodesix Inc. (BDSX) Company Bio


Biodesix, Inc. provides blood-based diagnostics services for patients with lung disease. It offers GeneStrat, a genomic blood test for patients who have been diagnosed with advanced lung cancer; and VeriStrat, a serum proteomic test that provides prognostic and predictive information for patients with non-small cell lung cancer. It is a data-driven diagnostic solutions company with proprietary AI platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease. The firm offers six diagnostic tests including: Nodify XL2, Nodify CDT, GeneStrat, VeriStrat, Bio-Rad SARS-CoV-2 ddPCR test and the Platelia SARS-CoV-2 test. . The company was founded in 2005 and is headquartered in Boulder, CO.


BDSX Latest News Stream


Event/Time News Detail
Loading, please wait...

BDSX Latest Social Stream


Loading social stream, please wait...

View Full BDSX Social Stream

BDSX Price Returns

1-mo -24.24%
3-mo -47.57%
6-mo -66.25%
1-year -56.28%
3-year -65.16%
5-year N/A
YTD -64.71%
2024 -16.85%
2023 -20.00%
2022 -56.52%
2021 -73.76%
2020 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!